Opioid drug conversion guidelines vary, conflict, study says

05/14/2013 | MedPage Today (free registration)

Guidelines for opioid drug conversion vary and sometimes conflict, and are based on single-dose studies that lack long-term data, according to a Purdue Pharma study presented at a meeting of the American Pain Society. The biggest variation was found in recommendations for hydromorphone and oxycodone. Dr. John Peppin of the Palliative Care Center in Lexington, Ky., agreed there is a problem, and physicians are aware of it.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN